HHC (hexahydrocannabinol) is best described as a semi-synthetic cannabinoid. While trace amounts may exist naturally in the cannabis plant, every HHC product on the market is manufactured in a lab through a chemical process called hydrogenation. The DEA has formally determined that HHC “does not occur naturally in the Cannabis sativa L. plant and can only be obtained synthetically,” classifying it as a Schedule I controlled substance.
That said, HHC is not the same thing as the fully synthetic cannabinoids found in products like K2 or Spice. The distinction matters, both for understanding what you’re actually consuming and for making sense of the legal landscape around it.
How HHC Differs From Fully Synthetic Cannabinoids
Fully synthetic cannabinoids, like those in K2 or Spice, are built from scratch using chemicals that have no relationship to the cannabis plant. They’re designed to activate the same brain receptors as THC but often do so far more powerfully and unpredictably, which is why they carry a much higher risk of dangerous side effects.
HHC starts from a real cannabinoid. The typical manufacturing process begins with CBD extracted from industrial hemp. That CBD is first converted into THC through an acid-driven chemical reaction, then the THC undergoes hydrogenation, a process that adds hydrogen atoms to the molecule’s structure. This is the same basic chemistry used to turn vegetable oil into margarine. The result is a molecule that looks almost identical to THC but with a fully saturated ring structure instead of a double bond. The United Nations Office on Drugs and Crime uses the term “semi-synthetic” for substances like HHC that are manufactured from naturally occurring cannabinoids, while noting that the label can be misleading since some newer compounds in this category appear to be made from non-cannabis precursors using purely synthetic methods.
How HHC Is Actually Made
Nearly all commercial HHC is produced from CBD sourced from industrial hemp. The process has two main steps. First, CBD is chemically rearranged into a form of THC. Then a metal catalyst, typically palladium or platinum, is used to force hydrogen gas into the THC molecule. This hydrogenation step is what creates HHC.
The process produces two mirror-image versions of the molecule: the 9R form and the 9S form. These two versions have different levels of biological activity, and commercial products show wide variability in the ratio between them. Analysis of hemp extracts marketed as HHC products found the R form was roughly twice as abundant as the S form, with R-HHC making up 17 to 26% of the product by dry weight and S-HHC making up 8 to 12%.
One notable finding from researchers who reviewed certificates of analysis for over 60 commercially available HHC products: the isomer ratios varied significantly from product to product. This inconsistency is a direct consequence of unregulated manufacturing, where different producers use different catalysts, reaction conditions, and purification methods.
Contamination Risks From Manufacturing
The hydrogenation process introduces a safety concern that doesn’t exist with plant-derived cannabinoids. The metal catalysts used (palladium and platinum) can leach into the final product as trace heavy metals, and researchers have flagged this as a significant toxicity concern.
Standard cannabis testing panels check for arsenic, mercury, lead, and cadmium because state regulations require it. But testing for palladium or platinum, the specific metals used in HHC production, is rarely requested or even offered by most cannabis analytical testing labs. This means a product could pass standard heavy metal screening while still containing residual catalyst metals that were never tested for.
How HHC Compares to THC in Effects
HHC activates the same cannabinoid receptors in the brain as THC, producing similar psychoactive effects: euphoria, altered perception, relaxation. However, research consistently shows it is less potent. This finding dates all the way back to 1940, when early bioassays first demonstrated HHC’s lower activity compared to THC. Primate studies, considered the most reliable model for evaluating psychoactive effects in cannabinoids, confirmed the same result.
The two forms of HHC also differ from each other. The 9R version has stronger receptor binding and greater pharmacological activity than the 9S version. Since commercial products contain unpredictable mixtures of the two, the actual potency of any given product is hard to gauge without lab testing.
HHC Shows Up on Drug Tests
If you’re wondering whether HHC will trigger a positive result on a standard cannabis drug test, the answer is yes. Research published in Forensic Science International found that HHC cross-reacts with standard immunoassay test strips designed to detect THC metabolites. In one study, urine tests gave positive results for up to 10 hours after ingestion or inhalation. Blood-based immunological assays also showed positive results for up to about 6 hours after oral use and 4 hours after inhalation.
These windows may vary depending on dose, frequency of use, and individual metabolism, but the core finding is clear: standard workplace and clinical drug screens do not distinguish HHC from THC.
Legal Status
The DEA’s position is unambiguous. In a 2023 letter to the Louisiana Department of Health, the agency stated that HHC meets the federal definition of “tetrahydrocannabinols” under the Controlled Substances Act because it is a synthetic equivalent of substances found in the cannabis plant. Because the DEA considers HHC obtainable only through synthesis, it falls outside the 2018 Farm Bill’s definition of legal hemp, making it a Schedule I substance at the federal level.
State-level legality varies. Some states have explicitly banned HHC alongside other hemp-derived cannabinoids like delta-8 THC, while others have not addressed it directly. The federal classification, however, means that HHC products exist in a legally precarious space regardless of where they’re sold.